IL6 and primary osteolysis: Whether rs2069845 is associated with the risk of orthopedic implant failure is currently unknown, but efforts to reduce IL-6 in preclinical models of particle-induced osteolysis have noted significantly reduced osteoclastogenesis following IL-6 antibody treatment [51], suggesting that lower levels of IL-6 post-operatively may be protective.